Physician profile
Paul Albert Shultz
NPI 1295148757
$17,270.29
in general payments reported to CMS, 2019-2025
19 companies · $3,640 in 2025
The $3,640 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $2,170 · 2021: $4,715 · 2022: $4,662 · 2023: $296 · 2024: $374 · 2025: $3,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,388 · Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,387.79 |
| Food and Beverage | $1,921.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,850.29 | 2019-2022 | |
| Nuvasive, INC. | $3,799.16 | 2019-2022 | |
| Abbott Laboratories | $2,566.22 | 2022-2025 | Eterna, Proclaim |
| Providence Medical Technology, INC. | $1,903.66 | 2025 | |
| Medtronic USA, INC. | $1,569.94 | 2019-2020 | |
| Wildwood Medical LLC | $1,005.32 | 2025 | |
| Stryker Corporation | $879.40 | 2019-2020 | |
| Arthrex, INC. | $676.65 | 2025 | |
| Zimmer Biomet Holdings, INC. | $381.14 | 2019-2020 | |
| Cerapedics INC. | $203.43 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Steelhead Surgical INC | $125.58 | 2024 | |
| Depuy Synthes Sales INC. | $120.18 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $42.71 | 2021-2022 | |
| Bioventus LLC | $34.38 | 2023 | Durolane |
| Radius Health, INC. | $32.49 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $31.17 | 2023 | Botox |
| Vertex Pharmaceuticals Incorporated | $17.20 | 2025 | |
| Mimedx Group, INC. | $16.95 | 2025 | |
| Acumed LLC | $14.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.